Skip to main content
. 2022 Jan 7;322(2):H319–H327. doi: 10.1152/ajpheart.00602.2021

Table 1.

Participant characteristics

Healthy Control Post-COVID-19 Healthy Vaccinated
Participants, n (men/women) 10 (5/5) 12 (5/7) 11 (4/7)
Age, yr 24 ± 4 [19–31] 22 ± 3 [19–27] 25 ± 6 [19–35]
BMI, kg/m2 25 ± 3 [20–29] 24 ± 3 [16–28] 24 ± 4 [20–32]
SBP, mmHg 114 ± 8 [100–128] 112 ± 13 [95–132] 108 ± 11 [89–122]
DBP, mmHg 68 ± 8 [50–78] 74 ± 7 [64–82] 66 ± 6 [54–74]
HR, beats/min 62 ± 7 [47–75] 69 ± 12 [52–91] 71 ± 9 [55–84]
HDL, mg/dL 59 ± 10 [46–79] 60 ± 7 [46–80] 51 ± 11 [39–69]
LDL, mg/dL 91 ± 16 [65–119] 87 ± 27 [26–109] 87 ± 16 [47–104]
Total CHO, mg/dL 169 ± 18 [136–183] 163 ± 29 [104–195] 159 ± 13 [135–176]
HbA1c, % 4.9 ± 0.3 [4.4–5.4] 4.7 ± 0.3 [4.3–5.2] 4.8 ± 0.2 [4.4–5.1]
Race/ethnicity, n
 Asian/Indian 1 1 2
 NH Black 1 0 2
 NH White 7 9 6
 Latino 0 2 1
 Mixed (2+ listed above) 1 0 0
Physical activity, %awake time
 Sedentary 64 ± 5 [57–71] 70 ± 10 [53–83] 67 ± 3 [64–73]
 Light 28 ± 5 [22–35] 25 ± 10 [16–44] 27 7 ± [16–44]
 Moderate-to-very vigorous 8 ± 4 [2–15] 4 ± 3 [1–8] 6 ± 3 [1–9]
Days since… Diagnosis Vaccine
131 ± 97 [12–357] 81 ± 36 [43–139]

Values are means ± SD and ranges [minimum–maximum]. BMI, body mass index; CHO, cholesterol; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HR, heart rate; LDL, low-density lipoprotein; NH, non-Hispanic; SBP, systolic blood pressure.